Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...
The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...
At the American Society of Hematology Conference in Orlando, new results from the MajesTEC-3 study show that combining ...
An infant botulism outbreak has sickened at least 39 babies across the U.S. and underscored the crucial role of a medication ...
People who search for INUSpheresis are usually already dealing with complex, long lasting illness. Many live with long COVID, ...
Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...
Knee injuries are common in athletes, accounting for 41% of all athletic injuries. But knee injuries aren’t limited to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results